Frank Yocca
2021
In 2021, Frank Yocca earned a total compensation of $1.2M as Senior Vice President and Chief Scientific Officer at BioXcel Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $112,912 |
|---|---|
| Option Awards | $700,887 |
| Salary | $333,250 |
| Other | $6,420 |
| Total | $1,153,469 |
Yocca received $700.9K in option awards, accounting for 61% of the total pay in 2021.
Yocca also received $112.9K in non-equity incentive plan, $333.3K in salary and $6.4K in other compensation.
Rankings
In 2021, Frank Yocca's compensation ranked 8,282nd out of 12,406 executives tracked by ExecPay. In other words, Yocca earned more than 33.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,282 out of 12,406 | 33rd |
Division Manufacturing | 3,665 out of 5,492 | 33rd |
Major group Chemicals And Allied Products | 1,630 out of 2,368 | 31st |
Industry group Drugs | 1,450 out of 2,089 | 31st |
Industry Pharmaceutical Preparations | 1,077 out of 1,536 | 30th |
Source: SEC filing on April 5, 2022.
Yocca's colleagues
We found three more compensation records of executives who worked with Frank Yocca at BioXcel Therapeutics in 2021.